2588 related articles for article (PubMed ID: 22464321)
1. MYC on the path to cancer.
Dang CV
Cell; 2012 Mar; 149(1):22-35. PubMed ID: 22464321
[TBL] [Abstract][Full Text] [Related]
2. Drosophila Myc: A master regulator of cellular performance.
Grifoni D; Bellosta P
Biochim Biophys Acta; 2015 May; 1849(5):570-81. PubMed ID: 25010747
[TBL] [Abstract][Full Text] [Related]
3. The Molecular 'Myc-anisms' Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics.
McAnulty J; DiFeo A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322239
[No Abstract] [Full Text] [Related]
4. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
Diolaiti D; McFerrin L; Carroll PA; Eisenman RN
Biochim Biophys Acta; 2015 May; 1849(5):484-500. PubMed ID: 24857747
[TBL] [Abstract][Full Text] [Related]
5. Myc's secret life without Max.
Gallant P; Steiger D
Cell Cycle; 2009 Dec; 8(23):3848-53. PubMed ID: 19887915
[TBL] [Abstract][Full Text] [Related]
6. MYC and transcription elongation.
Rahl PB; Young RA
Cold Spring Harb Perspect Med; 2014 Jan; 4(1):a020990. PubMed ID: 24384817
[TBL] [Abstract][Full Text] [Related]
7. Function of the c-Myc oncogenic transcription factor.
Dang CV; Resar LM; Emison E; Kim S; Li Q; Prescott JE; Wonsey D; Zeller K
Exp Cell Res; 1999 Nov; 253(1):63-77. PubMed ID: 10579912
[TBL] [Abstract][Full Text] [Related]
8. Myc phosphorylation in its basic helix-loop-helix region destabilizes transient α-helical structures, disrupting Max and DNA binding.
Macek P; Cliff MJ; Embrey KJ; Holdgate GA; Nissink JWM; Panova S; Waltho JP; Davies RA
J Biol Chem; 2018 Jun; 293(24):9301-9310. PubMed ID: 29695509
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
10. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
Lüscher B; Larsson LG
Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation.
Shi J; Stover JS; Whitby LR; Vogt PK; Boger DL
Bioorg Med Chem Lett; 2009 Nov; 19(21):6038-41. PubMed ID: 19800226
[TBL] [Abstract][Full Text] [Related]
12. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
[No Abstract] [Full Text] [Related]
13. MYC, Metabolism, and Cancer.
Stine ZE; Walton ZE; Altman BJ; Hsieh AL; Dang CV
Cancer Discov; 2015 Oct; 5(10):1024-39. PubMed ID: 26382145
[TBL] [Abstract][Full Text] [Related]
14. Biophysical and Structural Methods to Study the bHLHZip Region of Human c-MYC.
Zinzalla G
Methods Mol Biol; 2021; 2318():21-43. PubMed ID: 34019285
[TBL] [Abstract][Full Text] [Related]
15. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
Dang CV; Le A; Gao P
Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
[TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc/Max dimerization.
Clausen DM; Guo J; Parise RA; Beumer JH; Egorin MJ; Lazo JS; Prochownik EV; Eiseman JL
J Pharmacol Exp Ther; 2010 Dec; 335(3):715-27. PubMed ID: 20801893
[TBL] [Abstract][Full Text] [Related]
17. MYC, metabolism, cell growth, and tumorigenesis.
Dang CV
Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23906881
[TBL] [Abstract][Full Text] [Related]
18. Of Myc and Mnt.
Hooker CW; Hurlin PJ
J Cell Sci; 2006 Jan; 119(Pt 2):208-16. PubMed ID: 16410546
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription.
Struntz NB; Chen A; Deutzmann A; Wilson RM; Stefan E; Evans HL; Ramirez MA; Liang T; Caballero F; Wildschut MHE; Neel DV; Freeman DB; Pop MS; McConkey M; Muller S; Curtin BH; Tseng H; Frombach KR; Butty VL; Levine SS; Feau C; Elmiligy S; Hong JA; Lewis TA; Vetere A; Clemons PA; Malstrom SE; Ebert BL; Lin CY; Felsher DW; Koehler AN
Cell Chem Biol; 2019 May; 26(5):711-723.e14. PubMed ID: 30880155
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic activity of the c-Myc protein requires dimerization with Max.
Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]